Brian L. Strom - (Chair)
Brian L. Strom is the Inaugural Chancellor of Rutgers Biomedical and Health Sciences (RBHS) and the Executive Vice President for Health Affairs at Rutgers University. RBHS is comprised of eight schools and seven centers/institutes, and includes academic, patient care, and research facilities. These are most of the units of the former University of Medicine and Dentistry of New Jersey (UMDNJ), now dissolved, several Rutgers University units with health-related missions, and two research units historically co-managed by Rutgers and UMDNJ. The integration of these entities is designed to create a single organization that will lead to new models for clinical care and community service, educate the next generation of health care providers utilizing health care team approaches, and conduct research. Dr. Strom was formerly the Executive Vice Dean of Institutional Affairs, Founding Chair of the Department of Biostatistics and Epidemiology, Founding Director of the Center for Clinical Epidemiology and Biostatistics, and Founding Director of the Graduate Program in Epidemiology and Biostatistics, all at the Perelman School of Medicine of the University of Pennsylvania (Penn).
Dr. Strom is a nationally recognized leader in clinical research training. He was previously elected President of the Association of Clinical Research Training and was principal investigator (PI) or co-PI for eight National Institutes of Health (NIH)-funded clinical research training programs. More than 560 clinicians have been trained or are in training through the CCEB’s Master of Science in Clinical Epidemiology degree program, which Dr. Strom helped develop in the late 1970s and early 1980s and which he led for many years. All but about 55 MSCE trainees have appointments in academic or other research institutions. Dr. Strom received the 2004 Christian R. and Mary F. Lindback Award, Penn’s most prestigious teaching award, in recognition of the contribution he has made in his career to clinical research training.
Dr. Strom was a member of the Board of Regents of the American College of Physicians (ACP), and the Boards of Directors of the American Society for Clinical Pharmacology & Therapeutics (ASCPT), the American College of Epidemiology, and the Association for Patient-Oriented Research. He was previously President of ISPE. Dr. Strom was on the Drug Utilization Review Committee and the Gerontology Committee of the USP and the representative from the ACP to the USP. He served on the Drug Safety and Risk Management Advisory Committee for the FDA. Dr. Strom was Chair of the Institute of Medicine’s (IOM) Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Chair of the IOM Committee on Smallpox Vaccine Program Implementation, and was a member of the IOM Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program. He chaired the IOM Committee to Review the National Institute for Occupational Safety and Health’s Traumatic Injury Program, Consequences of Sodium Reduction in Populations, and Committee on a National Strategy for the Elimination of Hepatitis B and C, and was a member of the IOM Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. He served on the National Research Council Report Review Committee.
In 2001, Dr. Strom was elected as a member of the National Academy of Medicine. He most recently served on the Forum on Drug Discovery, Development and Translation. Dr. Strom has served on over ten HMD committees and has chaired over half of said committees.
Amy S. B. Bohnert, Ph.D., M.H.S., is an investigator with the Department of Veterans Affairs Center for Clinical Management Research (CCMR), an HSR&D Center of Innovation, and an Associate Professor with tenure in the Department of Psychiatry at the University of Michigan. She obtained a PhD in Public Health from the Johns Hopkins Bloomberg School of Public Health, with a focus on mental health epidemiology, and completed a fellowship in health services research with CCMR.
Dr. Bohnert is an expert in the design of observational studies using electronic health record and mortality databases, particularly when applied to the topics of overdose, suicide, and prescribing behavior. She has led VA-, NIH-, and CDC-funded projects on these topics, which has resulted in over 100 publications. Her studies of Veterans’ overdose and suicide mortality have been published in the Journal of the American Medical Association, the British Medical Journal, and the American Journal of Psychiatry. She was the senior author on a study examining concurrent opioid and benzodiazepine prescribing in connection to Veterans’ overdose deaths.
Dr. Bohnert has served in a scientific advisory role to the Centers for Disease Control and Prevention, including as a member of the expert panel for the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain, to the Food and Drug Administration, and to the Michigan Prescription Drug and Opioid Abuse Task Force. Her overall goal is to improve the quality of life and treatment outcomes for individuals who struggle with addiction and mental health conditions.
Tobias Gerhard is Associate Professor of Pharmacy and Epidemiology at Rutgers University. He serves as the inaugural Director of the Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS) where he conducts research on use, safety, and outcomes of prescription drugs. He is interested in novel epidemiological methods and their applications in the analysis of large clinical and administrative databases. Dr. Gerhard’s research has been funded by NIMH, PCORI, AHRQ, and several foundations. His work has been recognized with a Young Investigator Award from the Brain and Behavior Research Foundation and a New Investigator Award from the American Society of Clinical Psychopharmacology. Dr. Gerhard is a Fellow of ISPE and serves as a Special Government Employee on various FDA Advisory Committees.
Miguel Hernán, MD, DrPH, studies causal inference methods and implements them to evaluate strategies for the treatment and prevention of disease. Together with collaborators in several countries, he designs analyses of health care databases, epidemiologic studies, and randomized trials. Dr. Hernán teaches clinical data science at the Harvard Medical School, clinical epidemiology at the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, and causal inference methodology at the Harvard T.H. Chan School of Public Health, where he is the Kolokotrones professor of biostatistics and epidemiology and where he has mentored dozens of doctoral students and postdoctoral fellows. His book Causal Inference, co-authored with James Robins and freely available online, is used in graduate programs throughout the world. Dr. Hernán is a fellow of the American Association for the Advancement of Science, past chair of the American Statistical Association Section on Statistics in Epidemiology, past associate editor of the Journal of the American Statistical Association and of Biometrics, associate editor of the American Journal of Epidemiology, and an editor of Epidemiology. He has served on several committees of the National Academies of Sciences, Engineering, and Medicine.
Van L. King, Jr.
Van Lewis King, MD is a Professor at UT Health San Antonio. Dr. King received his MD from the University of Rochester School of Medicine and Dentistry. He completed his general psychiatry training at the Massachusetts General Hospital. He was a member of the faculty at the Johns Hopkins University School of Medicine for 25 years serving as the medical director of Addiction Treatment Services and the Center for Addiction and Pregnancy, prior to accepting a professorship at UT Health San Antonio in 2016. He is a highly trained general psychiatrist specializing in treatment of severe and chronic opioid use disorder. In addition to his daily clinical activities, he has been involved extensively in NIDA funded treatment services research related to patients with severe substance use disorder and how best to manage these frequently chronic conditions. He is a nationally recognized treatment expert in patients with severe opioid dependence (including pregnancy) and co-occurring psychiatric conditions and is developing a new program at UT Health San Antonio to treat adults with a wide variety of substance use disorder problems using the award-winning Adaptive Stepped Care treatment model he and his colleagues developed over the past 20 years. He is also active in Texas delivering buprenorphine maintenance waiver trainings to promote wider use of this medication to assist in treatment of patients with opioid use disorder.